Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.

Authors:
Xiran Jiang Meihong Ren Xue Shuang Huazhe Yang Dabao Shi Qingyuan Lai Yue Dong

J Magn Reson Imaging 2021 Feb 27. Epub 2021 Feb 27.

Department of Radiology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.

Background: Preoperative prediction of epidermal growth factor receptor (EGFR) mutation status in patients with spinal bone metastases (SBM) from primary lung adenocarcinoma is potentially important for treatment decisions.

Purpose: To develop and validate multiparametric magnetic resonance imaging (MRI)-based radiomics methods for preoperative prediction of EGFR mutation based on MRI of SBM.

Study Type: Retrospective.

Population: A total of 97 preoperative patients with lumbar SBM from lung adenocarcinoma (77 in training set and 20 in validation set).

Field Strength/sequence: T1-weighted, T2-weighted, and T2-weighted fat-suppressed fast spin echo sequences at 3.0 T.

Assessment: Radiomics handcrafted and deep learning-based features were extracted and selected from each MRI sequence. The abilities of the features to predict EGFR mutation status were analyzed and compared. A radiomics nomogram was constructed integrating the selected features.

Statistical Tests: The Mann-Whitney U test and χ test were employed for evaluating associations between clinical characteristics and EGFR mutation status for continuous and discrete variables, respectively. Least absolute shrinkage and selection operator was used for selection of predictive features. Sensitivity (SEN), specificity (SPE), and area under the receiver operating characteristic curve (AUC) were used to evaluate the ability of radiomics models to predict the EGFR mutation. Calibration and decision curve analysis (DCA) were performed to assess and validate nomogram results.

Results: The radiomics signature comprised five handcrafted and one deep learning-based features and achieved good performance for predicting EGFR mutation status, with AUCs of 0.891 (95% confidence interval [CI], 0.820-0.962, SEN = 0.913, SPE = 0.710) in the training group and 0.771 (95% CI, 0.551-0.991, SEN = 0.750, SPE = 0.875) in the validation group. DCA confirmed the potential clinical usefulness of the radiomics models.

Data Conclusion: Multiparametric MRI-based radiomics is potentially clinical valuable for predicting EGFR mutation status in patients with SBM from lung adenocarcinoma.

Level Of Evidence: 3 TECHNICAL EFFICACY: 2.

Download full-text PDF

 Source
http://dx.doi.org/10.1002/jmri.27579DOI Listing
February 2021

Publication Analysis

Top Keywords

egfr mutation
32
mutation status
24
preoperative prediction
12
lung adenocarcinoma
12
mri-based radiomics
12
sbm lung
8
deep learning-based
8
bone metastases
8
predict egfr
8
handcrafted deep
8
predicting egfr
8
spinal bone
8
mutation
8
prediction egfr
8
radiomics
8
learning-based features
8
multiparametric mri-based
8
status patients
8
egfr
8
status
6

Keyword Occurance

Similar Publications

Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.

Authors:
Meilinuer Abdurixiti Mayila Nijiati Rongfang Shen Qiu Ya Naibijiang Abuduxiku Mayidili Nijiati

Br J Radiol 2021 Apr 21:20201272. Epub 2021 Apr 21.

Department of Radiology, The First People's Hospital of Kashi Area, Kashi, Xinjiang, China.

Objectives: To assess the methodological quality of radiomic studies based on positron emission tomography/computed tomography (PET/CT) images predicting epidermal growth factor receptor (EGFR) mutation status in patients with non-small cell lung cancer (NSCLC).

Methods: We systematically searched for eligible studies in the PubMed and Web of Science datasets using the terms "radiomics", "PET/CT", "NSCLC", and "EGFR". The included studies were screened by two reviewers independently. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.

Authors:
Liang Wang Xing Wang Miao Huang Shi Yan Shaolei Li Chao Lv Nan Wu Yue Yang

Interact Cardiovasc Thorac Surg 2021 Apr 21. Epub 2021 Apr 21.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.

Objectives: This study aimed to evaluate the value of the high-risk-pattern histology (micropapillary and solid components) for predicting distant metastasis in lung adenocarcinoma and to determine the survival benefit with adjuvant targeted therapy for resected non-small cell lung cancer with high-risk-pattern histology.

Methods: Patients receiving surgery for non-small cell lung cancer were included in this retrospective study. Histological classification was performed according to 2015 World Health Organization classification. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

[Semiquantitative parameters of F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].

Authors:
X H Liao R F Wang M Liu X Q Chen Y Xiong L Nong L Yin B Y Zhang Y J DU

Beijing Da Xue Xue Bao Yi Xue Ban 2020 Oct;53(2):246-254

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

Objective: To explore the valuable predictors for evaluating progression-free survival (PFS) in patients with lung adenocarcinoma, we analyzed the potential roles of standardized uptake value (SUV)-derived parameters from F-FDG PET/CT, combining with the gene mutation states of epidermal growth factor receptor () and anaplastic lymphoma kinase (), and other clinical characteristics.

Methods: Data of 84 lung adenocarcinoma patients pre-treated, who underwent F-FDG PET/CT scans, gene mutations test, rearrangement assay and other relative tests, were retrospectively collected. Then a series of clinical parameters including / mutation status and SUV-derived features [maximum standardized uptake value (SUVmax), average of standardized uptake value (SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG)] were evaluated. Read More

View Article and Full-Text PDF
October 2020
Similar Publications

KRAS, BRAF, PIK3CA mutation frequency of radical prostatectomy samples and review of the literature.

Authors:
Atike Bahcivan Mehmet Gamsizkan Sinem Kantarcioglu Coskun Sengul Cangur Alpaslan Yuksel Aysegul Ceyhan Binnur Onal

Aging Male 2020 Dec;23(5):1627-1641

Department of Pathology, Duzce University, Duzce, Turkey.

Objective: The molecular basis of prostate cancer is highly heterogeneous. Our study aimed to perform the mutation analysis of , and immunohistochemical (IHC) evaluation of EGFR, HER2, p16, and PTEN to demonstrate new areas for targeted therapies.

Methods: A total of 24 prostatectomy samples diagnosed with adenocarcinoma were analyzed by microarray hybridization. Read More

View Article and Full-Text PDF
December 2020
Similar Publications

Utility of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-small Cell Lung Cancer.

Authors:
Moom R Roosan Isa Mambetsariev Rebecca Pharaon Jeremy Fricke Hatim Husain Karen L Reckamp Marianna Koczywas Erminia Massarelli Andrea H Bild Ravi Salgia

Chest 2021 Apr 17. Epub 2021 Apr 17.

City of Hope Comprehensive Cancer Center, Duarte, CA 91010. Electronic address:

Background: The utility of circulating tumor DNA (ctDNA) in detecting mutations and monitoring treatment response has not been well studied beyond a few actionable biomarkers in non-small cell lung cancer (NSCLC).

Research Question: How does the utility of circulating tumor DNA (ctDNA) compare to that of solid tumor biopsy in non-small cell lung cancer (NSCLC) patients?

Methods: We retrospectively evaluated 370 adult NSCLC patients treated at the City of Hope between November 2015 and August 2019 to assess the utility of ctDNA in mutation identification, survival, concordance with matched tissue samples in thirty-two genes, and tumor evolution.

Results: A total of 1688 somatic mutations were detected in 473 ctDNA samples from 370 NSCLC patients. Read More

View Article and Full-Text PDF
April 2021
Similar Publications